Telemonitoring Impact by the ApTelecare Software in Dialysis Patient

Study Overview
=================
Brief Summary
-----------------
The investigators proposed to conduct a retrospective study to evaluate the impact of the implementation of apTeleCare software on the management of dialysis patients at home in terms of the number and duration of hospitalizations. For this purpose, the investigators will compare patients' data over a 2-year interval before the introduction of Telemonitoring (January 2012 and December 2013 inclusive - Group 1) with patients data who have benefited from this application (between August 2016 and July 2018).

Official Title
-----------------
Telemonitoring Impact by the ApTelecare Software in Dialysis Patient

Conditions
-----------------
Chronic Renal Failure, Dialysis Related Complication

Intervention / Treatment
-----------------
* Device: Telemonitoring Software


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients (≥ 18 years) with no age limit; Patients receiving peritoneal dialysis on the investigation center between 2012 and 2014 (Group1) and between 2016 and 2018 (Group 2); Patient information in this retrospective study; Exclusion Criteria: Patients who have started a peritoneal dialysis program before the periods of investigation; Patients who have been equipped with apTeleCare during the dialysis program; Subject under guardianship, curators or safeguard of justice; Patient not affiliated to a French social protection;

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients without Telemonitoring with ApTelecare Software<br> | |
| Patients with implementation of Telemonitoring with ApTelecare<br> | Device: Telemonitoring Software<br>* Recovery of retrospective data in dialysis patients follow or not follow by a telemonitoring application.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cumulative duration (on retrospective two years of follow-up) of the unscheduled hospitalizations between the two patient groups. |  | up to two years. | 
| Cumulative duration (on retrospective two years of follow-up) of the scheduled hospitalizations between the two patient groups. |  | up to two years. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Total length of hospitalisation |  | For both groups. Every two months (follow-up visit) on a retrospective period of two years, the outcome 2 will be measured. The study duration will be of 5 months | 
| Number of events of cardiovascular complications |  | For both groups. Every two months (follow-up visit) on a retrospective period of two years. The study duration will be of 5 months | 
| Mortality rate |  | For both groups. At the end of this retrospective study (Study Period of 5 months). | 
| Rate of peritoneal infections |  | For both groups. At the end of this retrospective study.(Study Period of 5 months). | 
| Number of patient exit technique except death | For example transplant, hemodialysis | For both groups. At the end of this retrospective study. (Study Period of 5 months). | 
| Charlson score : Comorbidity index | This scale measure the comorbidity symptoms of patients at the beginning of the care by the physician. The minimum score will be 0 and the maximum will be 39. Its validation is based on a prediction of health French insurance, as well as on several clinical areas such as oncology or nephrology. | baseline | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Home Peritoneal Dialysis